 |
The Journal of Neuroscience, June 22, 2005, 25(25):6016-6024; doi:10.1523/JNEUROSCI.0692-05.2005
Previous Article | Next Article 
Neurobiology of Disease
Intravesicular Localization and Exocytosis of -Synuclein and its Aggregates
He-Jin Lee,
Smita Patel, and
Seung-Jae Lee
The Parkinson's Institute, Sunnyvale, California 94089
-Synuclein ( -syn), particularly in its aggregated forms, is implicated in the pathogenesis of Parkinson's disease and other related neurological disorders. However, the normal biology of -syn and how it relates to the aggregation of the protein are not clearly understood. Because of the lack of the signal sequence and its predominant localization in the cytosol, -syn is generally considered exclusively an intracellular protein. Contrary to this assumption, here, we show that a small percentage of newly synthesized -syn is rapidly secreted from cells via unconventional, endoplasmic reticulum/Golgi-independent exocytosis. Consistent with this finding, we also demonstrate that a portion of cellular -syn is present in the lumen of vesicles. Importantly, the intravesicular -syn is more prone to aggregation than the cytosolic protein, and aggregated forms of -syn are also secreted from cells. Furthermore, secretion of both monomeric and aggregated -syn is elevated in response to proteasomal and mitochondrial dysfunction, cellular defects that are associated with Parkinson's pathogenesis. Thus, intravesicular localization and secretion are part of normal life cycle of -syn and might also contribute to pathological function of this protein.
Key words: synuclein; Parkinson's disease; exocytosis; protein aggregation; vesicle; neurodegeneration
Received Feb 20, 2005;
revised May 19, 2005;
accepted May 22, 2005.
This article has been cited by other articles:

|
 |

|
 |
 
H.-M. Gao, P. T. Kotzbauer, K. Uryu, S. Leight, J. Q. Trojanowski, and V. M.-Y. Lee
Neuroinflammation and Oxidation/Nitration of {alpha}-Synuclein Linked to Dopaminergic Neurodegeneration
J. Neurosci.,
July 23, 2008;
28(30):
7687 - 7698.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. D. Gitler, B. J. Bevis, J. Shorter, K. E. Strathearn, S. Hamamichi, L. J. Su, K. A. Caldwell, G. A. Caldwell, J.-C. Rochet, J. M. McCaffery, et al.
The Parkinson's disease protein {alpha}-synuclein disrupts cellular Rab homeostasis
PNAS,
January 8, 2008;
105(1):
145 - 150.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. Danzer, D. Haasen, A. R. Karow, S. Moussaud, M. Habeck, A. Giese, H. Kretzschmar, B. Hengerer, and M. Kostka
Different Species of {alpha}-Synuclein Oligomers Induce Calcium Influx and Seeding
J. Neurosci.,
August 22, 2007;
27(34):
9220 - 9232.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Klegeris, B. I. Giasson, H. Zhang, J. Maguire, S. Pelech, and P. L. McGeer
Alpha-synuclein and its disease-causing mutants induce ICAM-1 and IL-6 in human astrocytes and astrocytoma cells
FASEB J,
October 1, 2006;
20(12):
2000 - 2008.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Leng and D.-M. Chuang
Endogenous alpha-synuclein is induced by valproic acid through histone deacetylase inhibition and participates in neuroprotection against glutamate-induced excitotoxicity.
J. Neurosci.,
July 12, 2006;
26(28):
7502 - 7512.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I-H. Liu, V. N. Uversky, L. A. Munishkina, A. L. Fink, W. Halfter, and G. J. Cole
Agrin binds {alpha}-synuclein and modulates {alpha}-synuclein fibrillation
Glycobiology,
December 1, 2005;
15(12):
1320 - 1331.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|